Cathy Eng
Impact in
- Oncology top 0.05%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Scott Kopetz (53 shared papers)George J. Chang (50 shared papers)Michael James Overman (51 shared papers)Jean‐Nicolas Vauthey (17 shared papers)Robert A. Wolff (45 shared papers)Miguel A. Rodrı́guez-Bigas (45 shared papers)John Michael Skibber (41 shared papers)Prajnan Das (49 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)Cancer (23 papers)Annals of Oncology (19 papers)International Journal of Radiation Oncology*Biology*Physics (17 papers)Clinical Colorectal Cancer (14 papers)
- Partner nations
- United StatesItalySpain
In The Last Decade
Cathy Eng
329 papers receiving 19.9k citations
Cathy Eng's Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 11.7k
- Hepatology 1.3k
- Cancer Research 1.3k
- Surgery 3.3k
- Pathology and Forensic Medicine 819
Countries citing papers authored by Cathy Eng
This map shows the geographic impact of Cathy Eng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy Eng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy Eng more than expected).
Fields of papers citing papers by Cathy Eng
This network shows the impact of papers produced by Cathy Eng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy Eng. The network helps show where Cathy Eng may publish in the future.
Co-authors
The 25 scholars most cited alongside Cathy Eng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 347 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy Hit paper breakdown → | 2009 | 1093 |
| 2 | Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases Hit paper breakdown → | 2006 | 1031 |
| 3 | Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases Hit paper breakdown → | 2005 | 891 |
| 4 | EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 776 |
| 5 | A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group Hit paper breakdown → | 2020 | 535 |
| 6 | 2008 | 469 | |
| 7 | Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2017 | 460 |
| 8 | Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial Hit paper breakdown → | 2019 | 460 |
| 9 | Treatment of Metastatic Colorectal Cancer: ASCO Guideline Hit paper breakdown → | 2022 | 433 |
| 10 | 2012 | 418 | |
| 11 | 2009 | 412 | |
| 12 | 2009 | 353 | |
| 13 | Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study Hit paper breakdown → | 2017 | 317 |
| 14 | 2011 | 309 | |
| 15 | Antiemetics: ASCO Guideline Update Hit paper breakdown → | 2020 | 297 |
| 16 | ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper Hit paper breakdown → | 2020 | 295 |
| 17 | 2007 | 293 | |
| 18 | 2007 | 281 | |
| 19 | Colorectal cancer Hit paper breakdown → | 2024 | 244 |
| 20 | 2017 | 237 |
About Cathy Eng
Cathy Eng is a scholar working on Oncology, Surgery, Pathology and Forensic Medicine, Cancer Research and Hepatology, having authored 347 papers that have together received 20.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (118 papers), Colorectal and Anal Carcinomas (67 papers), Colorectal Cancer Surgical Treatments (62 papers), Intraperitoneal and Appendiceal Malignancies (26 papers), Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (15 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Colorectal Cancer Screening and Detection (11 papers). The work is most often cited by research in Oncology (11.7k citations), Hepatology (1.3k citations), Cancer Research (1.3k citations), Surgery (3.3k citations) and Pathology and Forensic Medicine (819 citations). Cathy Eng has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Scott Kopetz, George J. Chang, Michael James Overman, Jean‐Nicolas Vauthey, Robert A. Wolff, Miguel A. Rodrı́guez-Bigas, John Michael Skibber, Prajnan Das, Eddie K. Abdalla and Steven A. Curley. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.